Found: 24
Select item for more details and to access through your institution.
Proteasome inhibition enhances the anti-leukemic efficacy of chimeric antigen receptor (CAR) expressing NK cells against acute myeloid leukemia.
- Published in:
- Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01604-y
- By:
- Publication type:
- Article
Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 3208, doi. 10.3390/cells10113208
- By:
- Publication type:
- Article
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 1, p. 152, doi. 10.3390/cells10010152
- By:
- Publication type:
- Article
Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myeloma.
- Published in:
- Cytometry. Part B, 2018, v. 94, n. 5, p. 611, doi. 10.1002/cyto.b.21636
- By:
- Publication type:
- Article
In Vitro Functionality and Endurance of GMP-Compliant Point-of-Care BCMA.CAR-T Cells at Different Timepoints of Cryopreservation.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1394, doi. 10.3390/ijms25031394
- By:
- Publication type:
- Article
Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of Glioma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 1943, doi. 10.3390/ijms24031943
- By:
- Publication type:
- Article
Common T-Cell-Receptor Motifs and Features in Patients with Cytomegalovirus (CMV)-Seronegative End-Stage Renal Disease Receiving a Peptide Vaccination against CMV.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1029, doi. 10.3390/ijms23031029
- By:
- Publication type:
- Article
Comparison of FACS and PCR for Detection of BCMA-CAR-T Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 2, p. 903, doi. 10.3390/ijms23020903
- By:
- Publication type:
- Article
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 10, p. 2469, doi. 10.3390/ijms20102469
- By:
- Publication type:
- Article
Comparison of single copy gene-based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19-directed CAR T cells in treated patients.
- Published in:
- International Journal of Oncology, 2022, v. 60, n. 5, p. N.PAG, doi. 10.3892/ijo.2022.5338
- By:
- Publication type:
- Article
Shaping of CD56<sup>bri</sup> Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal Photopheresis.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00547
- By:
- Publication type:
- Article
Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02207
- By:
- Publication type:
- Article
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01470-0
- By:
- Publication type:
- Article
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. 1, doi. 10.3389/fimmu.2021.670088
- By:
- Publication type:
- Article
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 7, p. 1195, doi. 10.1007/s00262-019-02354-4
- By:
- Publication type:
- Article
IL-10 inducible CD8<sup>+</sup> regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 11, p. 1695, doi. 10.1007/s00262-018-2230-0
- By:
- Publication type:
- Article
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma.
- Published in:
- Biomedicines, 2022, v. 10, n. 2, p. 373, doi. 10.3390/biomedicines10020373
- By:
- Publication type:
- Article
Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCR.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2820, doi. 10.3390/cancers12102820
- By:
- Publication type:
- Article
Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML).
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 2, p. 200, doi. 10.3390/jcm8020200
- By:
- Publication type:
- Article
Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 2, p. 419, doi. 10.1002/ijc.33212
- By:
- Publication type:
- Article
Combining selective inhibitors of nuclear export (SINEs) with chimeric antigen receptor (CAR) T cells for CD19-positive malignancies.
- Published in:
- Oncology Reports, 2021, v. 46, n. 2, p. N.PAG, doi. 10.3892/or.2021.8121
- By:
- Publication type:
- Article
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.670088
- By:
- Publication type:
- Article
Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T Cells.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.608167
- By:
- Publication type:
- Article
Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 5, p. 1312, doi. 10.1002/ijc.32201
- By:
- Publication type:
- Article